March 22, 2021 7:38am
As bond yields rise again and restoration of capital requirements for big banks that were suspended in the early months of the pandemic weigh on sentiment.
Earnings: BioLife Solutions (BLFS)
Pre-open indications: 4 BUYs and 2 SELLs; Mentioned: BLUE, BSTG, SLDB, AGTC, PSTI, CRSP
RMi’s daily report is a primer that may say little or a lot; yet it serves as insurance that all indications are being examined and evaluated.
Dow futures are DOWN -0.05% (-17 points), S&P futures are UP +0.19% (+7 points) and NASDAQ futures are UP +0.79% (+102 points)
U.S. stock futures were mixed early Monday,
European stocks followed mixed with the resulting from moves in the Turkish lira following a sudden upheaval at the country’s central bank,
Asia-Pacific stocks were also mixed after Fed’s previous moves ending some emergency measures put in place last year to help the financial industry deal with the pandemic.
Data Docket: investors housing market when the National Association of Realtors releases existing home sales for February; however, a decline of 2.8% is projected.
Let’s see what breaks as today’s market and sector appears mixed and susceptible …
During last week, the indexes posted losses with the Dow down -0.05%, the S&P 500 off by -0.8% and the Nasdaq -0.8%.
Friday’s evening’s recap: “sector bounces to some higher pricing, beats yesterday’s downdraft” … https://www.regmedinvestors.com/articles/11824
- The Nasdaq closed UP +99.07 points (+0.76%);
- The IBB closed up +1.70% and XBI closed up +3.26%
- Sector volume had definitely INCREASED with 22 of the 32-upside having higher than the 3-month average volume with the volume of 2 of 2-downside having higher than the 3-month average volume;
- The CBOE Volatility Index (VVIX: INDEX) was down -0.63. points or -2.92% at 20.95;
- Friday’s percentage (%) of the 32-upside were +0.43% (MESO) to +15.21% (MDXG) while the 2-downside ranges from -3.08% (PGEN) to -3.80% (SLDB);
March: 7 positive, 7 negative and 1 neutral closes
February: 9 positive, 10 negative closes and 1 holiday
January: 10 positive, 9 negative closes and 1 holiday
Companies in my headlights – It’s your decision; I provide an idea and context:
Maintaining Sell: Questions continue …
Biostage (BSTG) closed up +$0.13 to $1.45 with 605 shares traded after Thursday’s +$0.02 to $1.32 with 375 shares traded, Wednesday’s flat at $1.30 with 36 shares traded, Tuesday’s +$0.02 to $1.30 with 210 shares traded and last Monday’s +$0.02 to $1.28 with 425 shares traded.
Question#1: WHEN are the 10-K and 10-Q filings to be filed versus due?
Question#3: RSM US LLP, will their AUDIT “OPINION” be “COLARED” about the MANY operational issues lack of strategy and focus be?
MINORITY PUBLIC shareholders are waiting, watching and weighting responses to MAINTAIN their RIGHTS.
BUY from SELL:
Solid Biosciences (SLDB) closed down -$0.23 to $5.82 after Thursday’s -$0.60 to $6.05 after Wednesday’s +$0.22 to $6.65, Tuesday’s $6.43 and Monday’s $9.51 with a positive +$0.22 or +3.78% aftermarket indication after completing a $125 million public offering.
Pluristem (PSTI) closed up again +$0.10 to $5.56 after Thursday’s $0.19 to $5.46, Wednesday’s $5.27, Tuesday’s $5.30 and last Monday’s $5.51 with a positive +0.09 or +1.62% pre-market indication
CRISPR Therapeutics (CRSP) closed up +$6.04 to $129.61 after Thursday’s -$7.53 to $123.57, Wednesday’s +$0.53 to $131.10, Tuesday’s +$3.03 to $130.57 and last Monday’s +$2.99 to $133.60 with a positive +$0.29 or +0.22% pre-market indication.
bluebird bio (BLUE) closed up +$1.29 to $31.58 after Thursday’s $30.29, Wednesday’s $31.00, Tuesday’s $32.39 and Monday’s $33.25 with a positive +$0.40 or +1.27 pre-market indication.
SELL from BUY:
Applied Genetic Technologies (AGTC) closed up +$0.29 to $6.04 after Thursday’s +$5.75 after Wednesday’s +$0.04 to $5.80, Tuesday’s $5.76 and last Monday’s $5.87 with a negative -$0.04 or -0.66% pre-market indication.
The BOTTOM LINE: I STILL am a “beware or the cautious man” whose focus has always been “warning analysis” … earnings’ season is NOT over … my advice, trim and skim of ANY new highs … if one can!”
Many talk of horizons; “as I have said last week, my horizon is usually a Friday’s close …”
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.